Invention Grant
US07696336B2 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
有权
称为251P5G2的核酸和相应的蛋白质可用于治疗和检测癌症
- Patent Title: Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
- Patent Title (中): 称为251P5G2的核酸和相应的蛋白质可用于治疗和检测癌症
-
Application No.: US11549900Application Date: 2006-10-16
-
Publication No.: US07696336B2Publication Date: 2010-04-13
- Inventor: Arthur B. Raitano , Pia M. Challita-Eid , Aya Jakobovits , Mary Faris , Wangmao Ge
- Applicant: Arthur B. Raitano , Pia M. Challita-Eid , Aya Jakobovits , Mary Faris , Wangmao Ge
- Applicant Address: US CA Santa Monica
- Assignee: Agensys, Inc.
- Current Assignee: Agensys, Inc.
- Current Assignee Address: US CA Santa Monica
- Agency: Morrison & Foerster LLP
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C12N15/00 ; C12N5/00 ; C12P21/06
Abstract:
A novel gene 251P5G2 and its encoded protein, and variants thereof, are described wherein 251P5G2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 251P5G2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 251P5G2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 251P5G2 can be used in active or passive immunization.
Public/Granted literature
- US20070231261A1 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 251P5G2 USEFUL IN TREATMENT AND DETECTION OF CANCER Public/Granted day:2007-10-04
Information query
